FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine

The U.S. Food and Drug Administration granted emergency use authorization to Johnson & Johnson’s single-dose COVID-19 vaccine on Saturday, the third vaccine to be approved for emergency use in the U.S. during the pandemic.

Unlike the Pfizer and Moderna vaccines, Johnson & Johnson’s shot works with just one dose instead of two.

Officials hope a single-shot vaccine will help speed up vaccinations against the coronavirus, which has killed over 500,000 people in the U.S. and infected millions more.

The FDA said J&J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. One dose was 85% protective against the most severe COVID-19 illness.

Shipments of a few million doses to be divided among states could begin as early as Monday. By the end of March, J&J has said it expects to deliver 20 million doses to the U.S., and 100 million by summer.

Source:

https://www.msn.com/en-us/health/medical/fda-approves-johnson-26-johnsons-one-dose-covid-19-vaccine-for-emergency-use/ar-BB1e4LZt